ACC 2022

APOLLO Trial: Magnitude And Duration of Effects of A Short-interfering RNA Targeting Lipoprotein(a): A Placebo-controlled Double-blind Dose-ranging Trial

C. Michael Gibson and Steven Nissen discuss the APOLLO Trial presented at ACC 2022.

We Recommend